Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Campus Universitário, Londrina, PR, 86051-970, Brazil.
Mycopathologia. 2010 Mar;169(3):151-7. doi: 10.1007/s11046-009-9243-3. Epub 2009 Nov 8.
Histoplasma capsulatum var. capsulatum is a thermally dimorphic fungus that causes histoplasmosis. Fungal hemagglutination activity and cases of reactive hemophagocytic syndrome (RHS) have been reported in the disseminated form of disease. In the present study, soluble components of H. capsulatum var. capsulatum have been investigated for hemagglutinin activity and the capacity to induce hemophagocytosis in the mouse system. To analyze hemagglutinating activity, mouse red blood cells (RBC) (1% v/v in PBS) were incubated (37 degrees C, 1 h) with cell-free antigen (CFAg) from H. capsulatum var. capsulatum (isolate IMT/HC128) (RBC-CFAg) or previously heated CFAg (56 degrees C, 30 min) (RBC-hCFAg) or as control with PBS (RBC-PBS). Hemophagocytosis was analyzed by incubating BALB/c mouse peritoneal phagocytic cells (5 x 10(6) cells) with syngeneic RBC, sensitized or not with CFAg. In addition, mouse polyclonal antibodies were raised against syngeneic RBC-CFAg (anti-RBC-CFAg) and used to analyze CFAg chromatographic fractions (Sephadex G75/120) by immunoenzymatic assay (ELISA). Hemagglutinin activity was observed with RBC-CFAg, but not with RBC-hCFAg or RBC. Also, hemophagocytosis was observed with RBC-CFAg, but not with RBC. The anti-RBC-CFAg antibodies reacted with CFAg fractions corresponding to a molecular mass (MM) higher than 150 kDa. In conclusion, the yeast form of H. capsulatum var. capsulatum releases thermolabile soluble components with hemagglutinin activity and it has been demonstrated for the first time that soluble components of the same fungus induce syngeneic hemophagocytosis in the in vitro mouse system. Also, indirect analysis with antibodies suggests that high-MM components (>150 kDa) are responsible for the interaction with RBC.
荚膜组织胞浆菌荚膜变种是一种热双相真菌,可引起组织胞浆菌病。在疾病的播散形式中,已报道真菌血凝活性和反应性噬血细胞综合征(RHS)病例。在本研究中,研究了荚膜组织胞浆菌荚膜变种的可溶性成分的血凝活性以及在小鼠系统中诱导噬血细胞的能力。为了分析血凝活性,将小鼠红细胞(RBC)(在 PBS 中为 1%v/v)与荚膜组织胞浆菌荚膜变种(分离株 IMT/HC128)的无细胞抗原(CFAg)(RBC-CFAg)或先前加热的 CFAg(56°C,30 分钟)(RBC-hCFAg)或 PBS(RBC-PBS)孵育(37°C,1 小时)。通过将同基因小鼠腹膜吞噬细胞(5×10(6)个细胞)与用 CFAg 敏化或未敏化的同基因 RBC 孵育来分析噬血细胞作用。此外,针对同基因 RBC-CFAg 产生了小鼠多克隆抗体(抗 RBC-CFAg),并用于通过免疫酶测定法(ELISA)分析 CFAg 色谱级分(Sephadex G75/120)。用 RBC-CFAg 观察到血凝活性,但用 RBC-hCFAg 或 RBC 则没有。也观察到用 RBC-CFAg 诱导噬血细胞,但用 RBC 则没有。抗 RBC-CFAg 抗体与 CFAg 级分反应,其分子量(MM)高于 150 kDa。总之,荚膜组织胞浆菌荚膜变种的酵母形式释放具有血凝活性的热不稳定可溶性成分,并且首次证明相同真菌的可溶性成分在体外小鼠系统中诱导同基因噬血细胞。此外,用抗体进行的间接分析表明,高 MM 成分(>150 kDa)负责与 RBC 的相互作用。